Meeting
2012 ASCO Annual Meeting
Choice of chemotherapy in the treatment of metastatic squamous cell carcinoma of the anal canal.
Authors
Cathy Eng
University of Texas M. D. Anderson Cancer Center, Houston, TX
Cathy Eng , Jane Rogers , George J. Chang , Y. Nancy You , Prajnan Das , Miguel A. Rodriguez-Bigas , Aki Ohinata , Jonathan Phillips , James L. Abbruzzese , Robert A. Wolff
Disclaimer
This material on this page is ©2024 American Society of Clinical Oncology, all rights reserved. Licensing available upon request. For more information, please contact licensing@asco.org
Poster Details
Session Type
Poster Session
Session Title
Gastrointestinal (Noncolorectal) Cancer
Track
Gastrointestinal Cancer—Gastroesophageal, Pancreatic, and Hepatobiliary
Sub Track
Anal Cancer
Citation
J Clin Oncol 30, 2012 (suppl; abstr 4060)
DOI
10.1200/jco.2012.30.15_suppl.4060
Abstract #
4060
Poster Bd #
43C
Abstract Disclosures
Similar Posters
Poster
2021 ASCO Annual Meeting
A randomized phase III study of immune checkpoint inhibition with chemotherapy in treatment-naive metastatic anal cancer patients: A trial of the ECOG-ACRIN cancer research group (EA2176).
First Author: Marc Thomas Roth
Poster
2022 ASCO Annual Meeting
First-line lenvatinib plus pembrolizumab plus chemotherapy in esophageal squamous cell carcinoma: LEAP-014 trial in progress.
First Author: Jong-Mu Sun
First Author: Ana Oaknin
First Author: Sebasti´n Mondaca